Sponsors (4)
The resolution raises public and policymaker awareness of brain tumors and research needs, but delivers only symbolic recognition without providing funding or direct changes to care, creating a trade-off between visibility and concrete resources.
People with brain tumors (including children and youth) and their families will see increased national attention in May 2025 through designation of National Brain Tumor Awareness Month, which can improve early recognition, peer support, and public knowledge.
Patients, hospitals, and health systems may benefit because the resolution highlights research gaps and the need for basic research, which could encourage future funding, private research initiatives, or advocacy for improved treatments.
Policymakers and the public will receive clearer information about the scale of brain tumor diagnoses, deaths, and prevalence, helping to inform advocacy, policy discussions, and potential future resource decisions.
People with brain tumors are unlikely to see immediate improvements in care or treatment because the designation is largely symbolic and does not allocate funding or change clinical practice.
Patients and families could face increased expectations for new therapies or services if awareness rises but research funding and treatment access are not expanded to match that attention.
Based on analysis of 2 sections of legislative text.
Designates May 2025 as National Brain Tumor Awareness Month and states findings on incidence, prevalence, survival, mortality, and research gaps.
Introduced May 1, 2025 by Michael T. McCaul · Last progress May 1, 2025
Designates May 2025 as National Brain Tumor Awareness Month and presents findings about the frequency, survival, mortality, research gaps, and the need for greater public awareness about brain tumors. It cites estimated counts for diagnoses and deaths in 2024–2025, the number of Americans living with brain tumors, and a low five-year survival rate for primary malignant brain tumors, while noting limited approved treatments and slow progress in mortality reductions over the prior 30 years.